SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

95.2493613

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

22.43

624.24

EPS(TTM)

Face Value()

Div & Yield %

7.96

Back

Dar Credit & Capital standalone net profit rises 60.73% in the March 2026 quarter

May 16,2026

Net profit of Dar Credit & Capital rose 60.73% to Rs 3.07 crore in the quarter ended March 2026 as against Rs 1.91 crore during the previous quarter ended March 2025. Sales rose 41.78% to Rs 14.49 crore in the quarter ended March 2026 as against Rs 10.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 43.89% to Rs 10.13 crore in the year ended March 2026 as against Rs 7.04 crore during the previous year ended March 2025. Sales rose 23.80% to Rs 49.89 crore in the year ended March 2026 as against Rs 40.30 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	14.49	10.22	42	49.89	40.30	24
OPM %	70.74	72.21	-	69.21	69.88	-
PBDT	4.42	2.60	70	13.71	9.71	41
PBT	4.22	2.43	74	12.92	9.04	43
NP	3.07	1.91	61	10.13	7.04	44

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)